Raphael Pharmaceutical (RAPH) Return on Assets (2021 - 2025)

Raphael Pharmaceutical has disclosed Return on Assets across 5 years of filings, most recently posting 0.21% for Q3 2025.

• Return on Assets for Q3 2025 came in at 0.21%, down 10.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.21% (down 10.0% YoY), and the FY2025 annual result was 0.31%, down 20.0% from the prior year.
• Return on Assets came in at 0.21% for Q3 2025 at Raphael Pharmaceutical, down from 0.12% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.04% in Q4 2023 to a low of 0.39% in Q4 2024.
• The 5-year median for Return on Assets is 0.11% (2024), against an average of 0.13%.
• Peak annual rise in Return on Assets reached 18 bps in 2024, while the deepest fall reached 35 bps in 2024.
• Raphael Pharmaceutical's Return on Assets stood at 0.07% in 2021, then plunged by 117 bps to 0.15% in 2022, then surged by 73 bps to 0.04% in 2023, then plunged by 876 bps to 0.39% in 2024, then soared by 45 bps to 0.21% in 2025.
• The last three Return on Assets figures came in at 0.21% (Q3 2025), 0.12% (Q2 2025), and 0.16% (Q1 2025), per Business Quant data.